Terms & Conditions
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Long-Term Data From PARADIGM Trial Suggest Survival Benefit With PrimeC in ALS
2
Study Identifies NRN1 as Therapeutic Target Candidate for Alzheimer Disease
3
Fenebrutinib Achieves Primary End Point in Head-to-Head Trial, GB221 Begins First-in-Person Trial for SMA1, Air Pollution Linked to Increased AD Risk
4
AHS Issues Position Statement Calling for Routine Migraine Screening in Women
5